Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02971605

Organisation Name: Johns Hopkins University

Overal Status: Completed

Start Date: July 1, 2017

Last Update: September 10, 2019

Lead Sponsor: Johns Hopkins University

Brief Summary: The proposed pilot study will assess whether ingestion of a classic hallucinogen (psilocybin) leads to changes in emotion processing and neural circuitry that may predict repeated self-administration of this drug and underlie an atypical mechanism of abuse liability, which may vitally contribute to the understanding of the potential for abuse and the underlying mechanisms supporting abuse of classic hallucinogens.

Conditions:
  • Healthy


Total execution time in seconds: 0.24849891662598